| Vasocon-A Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Vasocon-A 0.5%-0.05% | solution | ophthalmic | 100.0 milliliter(s) | OTC |
| Vasocon-A 0.5%-0.05% | solution | ophthalmic | 100.0 milliliter(s) | OTC |
antazoline phosphate - The phosphate salt form of antazoline, an ethylenediamine derivative with histamine H1 antagonistic and sedative properties. Antazoline phosphate blocks the H1 histamine receptor and prevents the typical allergic symptoms that are caused by histamine activity on capillaries, skin, mucous membranes, gastrointestinal and bronchial smooth muscles. The histamine activities include vasodilation, bronchoconstriction, increased vascular permeability, pain, itching, and spasmodic contractions of gastrointestinal smooth muscles. Antazoline phosphate is used to provide symptomatic relieve of allergic symptoms.
naphazoline hydrochloride - The hydrochloride salt form of naphazoline, an imidazole derivative and a direct-acting sympathomimetic amine with vasoconstrictive properties. Upon ocular administration, naphazoline hydrochloride exerts its effect by acting on alpha-adrenergic receptors in the arterioles of the conjunctiva to produce vasoconstriction, resulting in decreased conjunctival congestion and diminished itching, irritation and redness.